Sensei Biotherapeutics, Inc. (SNSE)

33.38 +2.36 (+7.61%) USD  |  NASDAQ  |  Apr 06, 16:00
33.50 +0.12 (+0.36%) After-Hours: 20:00
More

Sensei Biotherapeutics Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for SNSE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Johnson & Johnson Upgrade
Eton Pharmaceuticals, Inc. Upgrade
Vir Biotechnology, Inc. Upgrade
Acurx Pharmaceuticals, Inc. Upgrade
Tango Therapeutics, Inc. Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade